By Tarun Sai Lomte New research explores how attention difficulties, sleep disruption, and cognitive control challenges ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

President Trump was recently spotted with a prominent blue bruise on his hand, sparking widespread speculation. While minor ...

Death cap mushroom poisonings in California have reached record levels. Many of those poisoned are immigrants.

Each Olympic cycle, athletes and support staff chase the latest cutting-edge knowledge in pursuit of Gold. In the Winter ...

Independent observational case series of LTR Pharma’s intranasal erectile dysfunction spray Spontan reports positive outcomes ...

After decades of misdiagnosis and missed signals, researchers are finally starting to close the gender gap that has long ...

Neurodegenerative diseases (NDs) are among the most urgent global health challenges, affecting millions worldwide and placing a growing burden on healthcare ...

Hypertension may be silent, but its consequences are not. Early detection and timely treatment can prevent heart attacks, strokes, and kidney failure. As the country observes Philippine Heart Month, ...

Strategic Advisory Leadership expands as Immorta Bio Advances Radical Life Extension Therapies toward the clinic MIAMI, Feb. 3, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company ...

Sanofi’s LEAP2MONO phase 3 study of venglustat to treat type 3 Gaucher disease meets all primary endpoints: Paris Tuesday, February 3, 2026, 13:00 Hrs [IST] Positive results fro ...

More to follow.